Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01770 |
| Species: | Homo sapiens |
| Position : | chr16:11075050-11075232 |
| Year: | 2025 |
| Title: | Defining Mechanistic Links Between the Non-Coding Variant rs17673553 in CLEC16A and Lupus Susceptibility |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 39796169 |
| MONDO: | |
| Tissue: | Heart |
| Tissue Ontology ID: | UBERON:0000948 |
| Cell Source: | iPSC-Cardiac Fibroblast |
| CVCL ID: | |
| Cell Type: | iPSC-derived cardiac fibroblast |
| Cell Ontology ID: | CL:0000057 |
| Experiment Type: | Functional perturbation assay |
| High Throughput Method: | |
| Low Throughput Method: | CRISPR Knockout, RT-RT-qPCR, Western blot |
| Target gene : | CLEC16A |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01452 | chr16:11075000-11075280 | Lymph node | Burkitt lymphoma cell | Burkitt lymphoma |